2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $572M | $633M | $705M | $890M | $1.1B |
Cost of Revenue | $0 | $0 | $0 | $0 | -$14M |
Gross Profit | $572M | $633M | $705M | $890M | $1.1B |
Gross Profit % | 100% | 100% | 100% | 100% | 101% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $183M | $216M | $241M | $307M | $450M |
Dep. & Amort. | $18M | $35M | $35M | $23M | $27M |
Def. Tax | -$6.7M | -$8.8M | -$9.4M | -$20M | $33M |
Stock Comp. | $22M | $21M | $21M | $26M | $35M |
Chg. in WC | $52M | $107M | -$113M | -$154M | -$122M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $1.8B | $716M | $1.2B | $2.2B | $2B |
ST Investments | $188M | $187M | $263M | $232M | $142M |
Cash & ST Inv. | $1.9B | $903M | $1.5B | $2.5B | $2.1B |
Receivables | $0 | $0 | $0 | $0 | $0 |
Inventory | -$2.4B | -$2B | -$2.4B | -$2.9B | $0 |
Axos Financial reported strong Q3 FY2025 results, including $700M in net loan growth, stable net interest margins (NIM), and a 19% year-over-year increase in book value per share; return on average common equity was 16% and return on average assets was 1.8%.
Net interest income was $275M (up 5.3% YoY), with a NIM of 4.78% (down 5 bps YoY); management expects NIM ex-FDIC loan purchase accretion to remain at the high end of the 4.25%-4.35% target range.
Credit quality remained solid: net annualized charge-offs were 9 bps, non-accrual loans declined by $66.5M QoQ, and non-performing assets fell to 79 bps of total assets; management does not anticipate material losses from current non-performing loans.
Operating expenses were well managed, with non-interest expense up only 0.6% QoQ; efficiency ratio is targeted to remain at or below current levels, with a focus on leveraging AI and technology for further cost control.
Forward outlook: Loan growth is expected in the high single-digit to low teens annual range; capital deployment includes $28M in Q3 share repurchases and $30.3M in April; management remains open to M&A, particularly in wealth/custody or specialty finance, but is disciplined on price.